Xingsu Zhike Soft Capsules, a new medicine researched and developed by China Shineway, received a new medicine certificate and production license. China Shineway was named as a "2008 Hong Kong Outstanding Enterprise" China Shineway received an honor as one of "The Hong Kong's 100 Most Influential Brands"   Our research on the "Application of Centella Selected Triterpenes in Preventing Membranous Nephropathy" was awarded with a certificate of invention patent by the State Intellectual Property Office Shenmai Injection of China Shineway was included in the list of The Ministry of Science and Technology of China's 2008-2009 National Torch Program   Our "Chinese Medicine Hi-Tech Integration and Automatic Control System in Production Process" project won the "Ten Years Achievement Award" of the National Development and Reform Commission of China Shineway received a "Corporate Social Responsibility Outstanding Award" in the 2008 Social Responsibility Forum Shineway was honored as the "Leading Enterprise of Pharmaceutical Manufacturing Industry in Hebei Province" and as one of the "Top 50 Most Profitable Enterprises in Hebei Province" by the Federation of Industrial Economic of Hebei Province   Shineway signed a memorandum of understanding with the University of Western Sydney for Complementary Medicine and the Experimental and Research Centre of Xiyuan Hospital of the China Academy of Chinese Medicine Sciences on joint research of a new Chinese medicine The China Red Cross honored China Shineway with "China Red Cross Medal" for our contribution in the Sichuan earthquake   Shineway's Jiangzhi Tongluo Soft Capsule and Shujin Tongluo Granule were included in the first batch of "Innovative New Products" of Hebei Province   China Shineway's Modern Technology and Quality Control Centre received accreditation of ISO/IEC 17025   China Shineway was selected as a "Top 100 Pharmaceutical Companies" in China again   China Shineway received two science and technology awards from the Hebei Province Pharmaceutical Industry Association   Shineway ranked among the "500 Most Valuable Trademarks in China" Stage two of China Shineway's ERP project commenced   China Shineway was honored as China Outstanding Integrity Enterprise again China Shineway was selected as the first batch of innovative enterprises of Hebei Province   New Injection workshop commenced operations. Total capacity now reaches 2 billion vials per annum to cater for business growth Forbes named China Shineway as one of the Emerging Chinese Enterprises of 2008